Authors: Lucas M et al.
Anesthesia & Analgesia, 142(4):653–663, April 2026
This retrospective cohort study examined outcomes associated with transfusion-free blood management and patient blood management (PBM) strategies in major noncardiac surgery. Using data from over 25,000 adult surgical admissions across two German hospitals, the authors compared three groups: nontransfusable patients managed with transfusion-free strategies, transfusable patients receiving PBM, and transfusable patients without PBM.
The findings are striking. Patients managed with transfusion-free blood strategies had significantly better outcomes compared to transfusable patients. Mortality was markedly lower, along with reductions in renal and respiratory complications, fewer readmissions, and shorter hospital length of stay. Notably, there were no myocardial infarctions reported in the transfusion-free group, compared to a small but measurable incidence in transfusable patients. Surgical site complications were similar between groups, suggesting that avoiding transfusion did not come at the cost of increased infection risk.
In the secondary analysis focusing on transfusable patients, those treated with PBM strategies also experienced improved outcomes compared to those without PBM. These included lower mortality, fewer surgical site infections, reduced renal and respiratory complications, and shorter hospital stays. Importantly, PBM was associated with fewer transfusions, lower blood loss, and fewer units transfused per patient. Interestingly, hospital readmissions were slightly higher in the PBM group, a finding that may reflect differences in discharge practices or patient selection rather than harm from PBM itself.
The physiologic rationale supports these findings. Transfusions, while sometimes necessary, carry risks including immunomodulation, volume overload, and inflammatory effects. PBM strategies—such as optimizing preoperative hemoglobin, minimizing intraoperative blood loss, and managing coagulopathy—aim to reduce these risks while preserving oxygen delivery.
This study reinforces the concept that transfusion avoidance is not simply a philosophical or religious accommodation but may represent a superior clinical strategy when applied appropriately. It also highlights that PBM is not just about reducing transfusions—it is about a comprehensive perioperative approach to blood conservation and patient optimization.
Key Points
- Transfusion-free blood management is associated with significantly lower mortality and complications
- PBM improves outcomes in transfusable patients compared to no PBM
- PBM reduces transfusion rates, blood loss, and units transfused per patient
- No increase in surgical site infections with transfusion-free or PBM strategies
- Slight increase in readmissions in PBM group may reflect system or patient differences
What You Should Know
This is one of the strongest real-world datasets supporting what many already suspect: transfusion should be avoided whenever safely possible. The data suggest that patients managed without transfusion—or with structured PBM programs—do better across multiple clinically meaningful outcomes. For anesthesia providers, this means aggressively addressing preoperative anemia, minimizing intraoperative blood loss, and using transfusion as a last resort rather than a default. Hospitals that have not fully implemented PBM programs are likely leaving both quality and cost improvements on the table.
We want to thank Anesthesia & Analgesia for allowing us to summarize and share this important work with the anesthesia community.